Erik Vahtola

Active Biotech (Sweden) — Sweden

Medicine · Health Sciences

7h-index294citations14works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cardiovascular Function and Risk Factors(3), S100 Proteins and Annexins(3), Heart Failure Treatment and Management(2), Diabetes Treatment and Management(2), Multiple Myeloma Research and Treatments(2)

Publications14 total

Preclinical Efficacy of Tasquinimod in Myelodysplastic Neoplasms: Restoring Erythropoiesis and Mitigating Bone Loss
2025· 1 citedOpen Access
Clinical activity of novel targeting of S100A9 with tasquinimod for relapsed and refractory multiple myeloma (RRMM).
Journal of Clinical Oncology·2025
Tasquinimod, an S100A9 Inhibitor, in Combination with Ixazomib, Lenalidomide, and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Blood·2024· 3 cited
Phase 1 study of tasquinimod, an S100A9 inhibitor, alone and in combination with IRd for relapsed and refractory multiple myeloma (RRMM).
Journal of Clinical Oncology·2023
Trender inom utvecklingen av onkologiska läkemedel
Työväentutkimus Vuosikirja·2019Open Access
Effects of Levosimendan on Cardiac Gene Expression Profile and Post-Infarct Cardiac Remodelling in Diabetic Goto-Kakizaki Rats
Basic & Clinical Pharmacology & Toxicology·2011· 17 citedOpen Access
Diabetic cardiomyopathy and post-infarct ventricular remodelling : Effects of levosimendan in a rodent model of type II diabetes
Työväentutkimus Vuosikirja·2011· 1 citedOpen Access
Effects of the calcium sensitizer OR‐1896, a metabolite of levosimendan, on post‐infarct heart failure and cardiac remodelling in diabetic Goto–Kakizaki rats
British Journal of Pharmacology·2010· 13 citedOpen Access
Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat
Cardiovascular Diabetology·2010· 54 citedOpen Access
Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats
Journal of Hypertension·2009· 29 cited
Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats.
PubMed·2009· 28 cited
Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat
Journal of Hypertension·2008· 69 cited
Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats
British Journal of Pharmacology·2007· 78 citedOpen Access
704 Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats
European Journal of Heart Failure Supplements·2006· 1 cited

Frequent Co-authors

Marjut Louhelainen(8), Saara Merasto(8), Eero Mervaala(8), Petri Kaheinen(7), Jouko Levijoki(7), Ville Kytö(5), Piet Finckenberg(5), Hanna Leskinen(3), Ilkka Tikkanen(3), Dan T. Vogl(3), Yulia Nefedova(3), E. Paul Wileyto(3), Cynthia Diaczynsky(3), Inna Strakovsky(3), Eva Bondesson(3), Helén Tuvesson(3), Adam D. Cohen(3), Sandra P. Susanibar-Adaniya(3), Adam Waxman(3), Alfred L. Garfall(3)